Dr. Nancy A. Little, MD

Dr. Little practices at Adventist Health Lodi Memorial in Lodi, California, part of Adventist Health.

Dr. Little's NPI, 1679685374, was assigned on August 31, 2006. Dr. Little graduated from Sidney Kimmel Medical College in 1983. Dr. Little holds California license G65454.

Dr. Little's primary practice is Adventist Health Lodi Memorial, at 975 S Fairmont Avenue, Lodi, CA 95240 in San Joaquin County. The practice phone is (209) 334-3411.

Dr. Little's primary practice is Adventist Health Lodi Memorial in Lodi, California, part of Adventist Health. Dr. Little is also affiliated with Sutter Amador Hospital. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Little to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Little practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Little's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Little is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Little's licenses on file in 3 states: California, Texas and North Carolina.

Dmand AI lists bladder disease, enlarged prostate, pelvic prolapse, urinary endoscopy, UTI, vaginal prolapse repair and vaginal repair among the conditions Dr. Little treats.

CMS data shows 930 Medicare services from Dr. Little across 11 procedure codes in 2024, for 274 Medicare patients. Medicare paid $74,377 for them.

CMS counts 274 Medicare patients who saw Dr. Little in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Little's median patient age at 75, with 96% women.

In 2024, Dr. Little wrote 508 Medicare Part D claims for 228 patients. 59% of them were for generic drugs. CMS names the drug for 418 of them, across 11 drugs with 11 or more claims each, at $195,387 in total drug cost. In 2023, CMS named 524 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Little for performance year 2024, reported through an alternative payment model (APM). Dr. Little accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Little as offering telehealth.

Dmand AI links 5 papers to Dr. Little. The most frequent topics are Prostatic Neoplasms. Dr. Little has published most often in J Urol. Dr. Little's most frequent co-authors are Michael Cookson, MD and Arthur Edward Marlin.

CMS Open Payments shows 272 general payments to Dr. Little from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Allergan Inc. paid the most, $24,680.

Dmand AI lists 1 award for Dr. Little.

Dr. Little graduated from Sidney Kimmel Medical College in 1983. Dr. Little is a member of ACS.

Dr. Little is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.